The rodent established cell lines LTk-and NIH 3T3 have been used as recipients in gene transfer experiments to study the effect of interferon treatment on the genetic and oncogenic transformation by several genes of viral and cellular origin. Our results show that interferon severely inhibits, to a similar extent, the stable transformation of Ltk-and NIH 3T3 cells by the chicken thymidine kinase (tk) In our initial studies we used the growth-controlled mouse fibroblast cell line NIH 3T3 as a recipient for DNA-mediated gene transfer. Several human oncogenes have been detected by their ability to induce morphological transformation of these cells (2, 9). As donors we used DNAs from simian virus 40 (SV40), cells transformed with Harvey murine sarcoma virus (v-Ha-ras), and the activated cellular oncogenes from the human tumor-derived cells lines T24 and SK-LU-1. The oncogene of the T24 bladder carcinoma cell line is the human homolog (human c-Ha-ras) of the Harvey murine sarcoma virus oncogene (v-Ha-ras) (1, 3, 16, 23) , whereas the oncogene of the SK-LU-1 lung carcinoma cell line is the human homolog (human c-Ki-ras) of the Kirsten murine sarcoma virus oncogene (v-Ki-ras) (1, 3, 14, 20, 24) .
Interferons (IFNs) are a family of proteins produced by vertebrate cells in response to virus infection or some other stimuli. They are secreted from the producing cell and when in contact to another cell activate in it a pleiotropic response leading to antiviral, antitumor, and immunomodulatory action (7, 26) . Although much is known about the antiviral action of IFN (10) , the molecular mechanisms involved in its antitumor action remain unknown. By using DNA-mediated gene transfer techniques, Dubois et al. have reported on the inhibitory effect of IFN on the transformation of the herpes virus tk gene or the dihydrofolate reductase (dhfr) gene from hamster ovary cells when Ltk-cells were used as the recipient (5) . We have examined whether IFN inhibits the transforming potentiality of activated human oncogenes, what the level of this inhibition is, and whether IFN discriminates among viral genes, cellular genes, and oncogenes.
In our initial studies we used the growth-controlled mouse fibroblast cell line NIH 3T3 as a recipient for DNA-mediated gene transfer. Several human oncogenes have been detected by their ability to induce morphological transformation of these cells (2, 9) . As donors we used DNAs from simian virus 40 (SV40), cells transformed with Harvey murine sarcoma virus (v-Ha-ras), and the activated cellular oncogenes from the human tumor-derived cells lines T24 and SK-LU-1. The oncogene of the T24 bladder carcinoma cell line is the human homolog (human c-Ha-ras) of the Harvey murine sarcoma virus oncogene (v-Ha-ras) (1, 3, 16, 23) , whereas the oncogene of the SK-LU-1 lung carcinoma cell line is the human homolog (human c-Ki-ras) of the Kirsten murine sarcoma virus oncogene (v-Ki-ras) (1, 3, 14, 20, 24) .
Virus-induced mouse fibroblastoid IFN (containing 15% a and 85% a species) was prepared and partially purified on an antibody affinity column at a specific activity of 4 x 107 to 6 X 107 U/mg (generously provided by the late K. Paucker). Titrations were carried out in mouse L-929 cells with vesicular stomatitis virus as a challenge virus against a mouse IFN standard (G002-90511) from the Antiviral Substances Program, National Institutes of Health, Bethesda, Md., and are given in reference units. The mouse NIH 3T3 cell line used here responds to IFN, since after 18 h of treatment with 500 U/ml the replication of vesicular stomatitis virus was * Corresponding author.
inhibited and there was induction of 2-SA synthetase activity (15) .
To determine whether IFN alters oncogenic transformation, NIH 3T3 cells were mock treated or treated with various concentrations of IFN for 4 to 8 h. Donor DNA (1 ml) was added as a calcium phosphate precipitate over the cultures (10 ml) as described previously (17) . After 12 to 14 h of incubation at 37°C, the medium was replaced with 10 ml of fresh medium with or without IFN. One cultures (Table 3 ). These findings suggest that the expression of oncogenes is inhibited to some extent by IFN. However, the number of foci in IFN-treated cultures remained always lower than in untreated cultures, indicating that the stabilization-integration of DNA also is blocked by IFN.
Although the experiments described thus far were camed out with viral or cellular DNA, it was of interest to establish whether IFN similarly inhibits the transformation ability of cloned genes. In addition, it was of importance to determine whether IFN could influence the transformation of two contiguous genes and whether normal genes and oncogenes were equally inhibited. A derivative of plasmid pSV2-gpt (12) was constructed in which the cloned c-Ha-ras oncogene from T24 cells was introduced adjacent to the Ecogpt gene. This construct referred to as PTBG-1 is described elsewhere (13) . PTBG-1-transformed cells were split and grown in either mycophenolic acid containing medium or in medium containing 5% calf serum. Doses of IFN between 100 and 1,000 U/ml inhibited Ecogpt and oncogenic transformation by about 90% (Table 4) . When transformation was carried out with plasmid pSV2-gpt containing only the Ecogpt gene, a similar percent inhibition was found with IFN treatment. We needed to eliminate the possibility that the IFN effect b Cells were preincubated for 4 h with 500 U of IFN per ml. The conditions of the experiments were the same as in Table 1 , experiment 3. The total number offoci were scored from the same plates by visual inspection at 15, 20, and 30 days. The percentages of foci obtained in IFN-treated cultures relative to those in nontreated cultures on the same days are located within parentheses. Numbers represent total foci per experiment. was specific for viral sequences (those provided by SV40).
To that end, we used the cloned chicken thymidine kinase (tk) gene (18) as the control and obtained similar results (Table 4) in agreement with a previous report (5) on the inhibition by IFN of transformation of Ltk-cells with the cloned herpes tk gene. Thus, IFN inhibited normal genes and oncogenes to similar extent. There was some indication that IFN increased the appearance of flat colonies. This would be consistent with an inhibition of oncogene expression, as indicated in Table 3 . In this regard, two recent reports have shown a selective reduction of c-myc mRNA in Daudi cells by human IFN (8) and a reduction by mouse IFN in the amount of c-Ha-ras specific mRNA and p21 protein in a clonal line of NIH 3T3 cells oncogenically transformed by an activated human ras gene (22) . The calcium phosphate DNA coprecipitate method has been widely used to introduce defined genes into cultured animal cells. It has been shown that the exogenous DNA sequences incorporated by the transformed cells became covalently ligated together in a new genetic unit (19) , which eventually integrates into the host cell chromosome (21) . DNA recombination appears to be the mechanism involved in DNA joining after transfection (4, 25) . The results presented here show that IFN severely inhibits transformation of cultured animal cells by several genes of viral or cellular origin in the calcium phosphate DNA coprecipitate transfection assay. This inhibition appears to occur at the level of DNA stabilization or integration, or both, of the incorporated exogenous DNA sequences. Our studies do not determine whether IFN inhibits genetic transformation by enhanced degradation of the incorporated DNA, by decrease enzymic joining of DNA into large concatemeric forms, by integration into the host genome, or by a combination of these. Although IFN causes a turnover of Okazaki fragments in some cells (11) , we favor the ligation-integration inhibition since we have shown that IFN does not induce degradation of cytoplasmic vaccinia DNA, as observed either in the course of virus infection (6) 
